- Home
- ยป
- Our Product Range
- »
- Bandrone Tablets 150 Mg
Bandrone Tablets 150 Mg
Ibandronic Acid Tablets
| Strength | 150 mg |
| Pack Type | Strips |
| Drug Composition | Ibandronic Acid 150mg |
| Shelf Life | 36 Months |
| Usage/Application | To Treat Osteoporosis |
| Also Gives | Third Party Manufacturing |
| Country of Origin | Made in India |
Bonviva (Ibandronic Acid) 150 mg Film-Coated Tablets
Manufactured by Roche (or licensed partners)
General Information
*Generic Name: Ibandronic Acid / Ibandronate Sodium
*Brand Name Bonviva (also sold under names like Bondronat in injection form)
Strength: 150 mg
Form: Film-coated tablet
Color: White to off-white, oblong
Imprint May vary depending on country and manufacturer batch
---
Indications
Bonviva is primarily used for the treatment and prevention of:
Osteoporosis in postmenopausal women
*Reduction of vertebral fractures risk
---
Pharmacological Class
ClassBisphosphonate
Mechanism of Action Inhibits osteoclast-mediated bone resorption, thereby strengthening bone mass
---
Dosage and Administration
Dose 150 mg once a month
Route Oral
Instructions
Take on an empty stomach, with a full glass of plain water
Do not lie down, eat, or drink anything else for at least 60 minutes after taking
Take the tablet on the same day each month
---
Contraindications
Hypocalcemia (low calcium levels)
Esophageal abnormalities
Inability to sit or stand upright for at least 60 minutes
Known hypersensitivity to ibandronate or any tablet ingredient
Side Effects
Common:
Gastrointestinal irritation (heartburn, nausea)
Musculoskeletal pain (joint, bone, or muscle pain)
Flu-like symptoms after first dose
Rare but serious:
Esophagitis
Osteonecrosis of the jaw (ONJ)